Marre M. L'atteinte rénale chez le diabétique. In : INSERM Ec, ed. Insuffisance rénale chronique. Étiologies. moyens de diagnostic précoce, prévention. Paris, 1997 : 83-96.
The diabetes control and complications trial research group. Effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 ; 329 : 977-86.
UK prospective diabetes study group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 ; 352 : 837-53.
The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert comittee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997 ; 20 : 1183-97.
Pirart J. Diabète et complications dégénératives : présentation d'une étude prospective portant sur 4 400 cas observés entre 1947 et 1973. Diabetes Metab 1977 ; 3 : 97-107, 173-82, 245-56.
Orchard TJ, Dorman JS, Maser RE, et al. Prevalence in complications in IDDM by sex and duration. Pittsburgh epidemiology of diabetes complications study II. Diabetes 1990 ; 39 : 1116-24.
Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996 ; 39 : 940-5.
Fioretto P, Steffes MW, Barbosa J, Rich SS, Miller ME, Mauer M. Is diabetic nephropathy inherited ? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes 1999 ; 48 : 865-9.
Earle K, Walker J, Hill C, Viberti G. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1992 ; 326 : 673-7.
Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease : evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989 ; 320 : 1161-5.
Krolewski AJ, Canessa M, Warram JH, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes. N Engl J Med 1988 ; 318 : 140-5.
Viberti GC, Keen H, Wiseman M. Raised arterial pressure in parents of proteinuric insulin dependent diabetic patients. Br Med J 1987 ; 295 : 515-7.
Roglic G, Colhoun HM, Stevens LK, Lemkes HH, Manes C, Fuller JH. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus : the EURODIAB IDDM complications study. Diabetic Med 1998 ; 15 : 418-26.
Fagerudd JA, Tarnow L, Jacobsen P, et al. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes 1998 ; 47 : 439-44.
Cordonnier D, Zmirou D, Benhamou PY, Halimi S, Ledoux F, Guiserix J. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin dependent) diabetes mellitus. Diabetolagia 1993 ; 36 : 164-70.
American Diabetes Association. Consensus statement : diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care 1996 ; 1 (suppl. 1) : S103-7.
Parving HH, Gall MA, Skott P, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992 ; 41 : 758-62
Bouhanick B, Berrut G, Fressinaud P, Marre M. Microalbuminuria and type 2 diabetes : practical interpretation and therapeutic ' consequences. Diabetes Metab 1995 ; 21 : 295-8.
Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997 ; 157 : 1413-8.
Canani LH, Gerchman F, Gross JL. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 1999 ; 48 : 909-13.
Faronato PP, Maioli M, Tonolo G, et al. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. Diabetologia 1997 ; 40 : 816-23.
Rogus JL, Krolewski AJ. Using discordant sib pairs to map loci for qualitative traits with high sibling recurrence risk. Am J Hum Genet 1996 ; 59 : 1376-81.
Spielman R, McGinnis RE, Ewens WJ Transmission test for linkage desequilibrium : the insulin-dependent diabetes mellitus. Am J Hum Genet 1993 ; 52 : 506-16.
Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996 ; 273 : 1516-7.
Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski A. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q. Results of novel discordant sib-pair analysis. Diabetes 1998 ; 47 : 1164-9.
Ko BCB, Lam KSL, Wat NMS, Chung SSM. An (A-C) dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early onset diabetic retinopathy in NIDDM patients. Diabetes 1995 ; 44 : 727-32.
Heesom AE, Hibberd LM, Millward A, Demaine AG. Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 1997 ; 46 : 287-91
Vlassara H. Recent progress in advanced glycation endproducts and diabetic complications. Diabetes 1997 ; 46 (suppl. 2) : S19-25.
Hudson BI, Stickland MH, Grant PJ. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene. Prevalence in type 2 diabetes and ethnic groups. Diabetes 1998 ; 47 : 1155-7.
Coonrod BA, Ellis D, Becker DJ, et al. Predictors of microalbuminuria in individuals with IDDM. Diabetes Care 1993 ; 16 : 1376-83.
Mulec H, Johnson SA, Bjorck S. Relation between serum cholesterol and diabetic nephropathy. Lancet 1990 ; 335 : 1537-8.
Watts GF, Powrie JK, O'Brien SF, Shaw KM. Apolipoprotein B independently predicts progression of very-low-level albuminuria in insulin-dependent diabetes mellitus. Metabolism 1996 ; 45 : 1101-7.
Chowdhury TA, Dyer PH, Kumar S, et al. Association of apolipoprotein E2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 1998 ; 47 : 278-80
Onuma T, Laffel LMB, Angelico MC, Krolewski AS. Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol 1996 ; 7 : 1075-8.
Hadjadj S, Gallois Y, Bouhanick B, et al. Lack of contribution of lipid gene polymorphisms to IDDM nephropathy - the GENEDIAB study. Diabetologia 1998 ; 41 (suppl. 1) : A293.
Parving HH. Renoprotection in diabetes : genetic and non-genetic risk factors and treatment. Diabetologia 1998 ; 41 : 745-59.
Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981 ; 19 : 410-5.
Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986 ; 77 : 1925-30.
Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984 ; 311 : 89-93.
Cambien F, Alhenc-Gelas F, Herbeth B, et al. Familial resemblance of plasma angiotensin-converting enzyme level : the Nancy study. Am J Hum Genet 1988 ; 43 : 774-80.
Marre M, Bernadet P, Gallois Y, et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994 ; 43 : 384-8.
Fujisawa T, Ikegami H, Kawagushi Y, et al. Meta-analysis of association of insertion/deletion polymoiphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998 ; 41 : 47-53.
Staessen JA, Wang JG, Ginocchio G, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme and cardiovascular-renal risk. J Hypertens 1997 ; 15 : 1579-92.
Tarnow L, Gluud C, Parving HH. Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 1998 ; 13 : 1125-30.
Marre M, Jeunemaitre X, Gallois Y, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 1997 ; 99 : 1585-95.
Barnas U, Schmidt A, Illevitch A, et al. Evaluation of risk factors for the development of nephropathy in patients with IDDM : insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia 1997 ; 40 : 327-31.
Parving HH, Jacobsen P, Tarnow L, et al. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme : observational follow-up study. Br Med J 1996 ; 313 : 591-4.
Hadjadj S, Belloum R, Gallois Y, et al. Contribution of the angiotensin I converting enzyme I/D polymorphism to the development and progression of diabetic nephropathy in type 1 diabetes : a 6-year follow-up observational study. Diabetes 1999 ; 48 (suppl. 1) : A 36.
Penno G, Chaturvedi N, Talmud PJ, et al. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients. Findings from the EUCLID randomized controlled trial. Diabetes 1998 ; 47 : 1507-11.
Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of cholesterol ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med 1998 ; 338 : 86-93.
Passa P, Chatellier G. The DIAB-HYCAR Study Diabetologia 1996 ; 39 : 1662-7.
